Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05302713
NCT05302713WithdrawnNot Applicable

Evaluating Changes in Quality of Life and Epigenetic Methylation From Antiorbital Ionic Calcium in Older Adults With Chronic Conditions

National University of Natural Medicine2 sites in 1 countryStarted: April 1, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
2
Primary Endpoint
Rate of Biological Aging
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to determine the mechanistic effects of an ionic calcium supplement in adults with atrial fibrillation, osteoarthritis, and hypertension. The study aims to determine if ionic calcium supplementation affects quality of life, rate of biological aging, bone densitometry, and blood biomarkers of bone metabolism over a six month period compared to non-ionic calcium comparator supplement.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
55 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Rate of Biological Aging

Time Frame: Week 24

Dunedin Pace of Aging Calculated objective measure of the rate of epigenetic aging

Patient Reported Outcomes Measurement Information system-29 Physical Function Sub-domain

Time Frame: Week 24

Quality of Life

Secondary Outcomes

  • Changes in Cognition(Week 24)
  • Changes in Systolic and Diastolic Blood Pressure(Week 24)
  • Changes in Mood(Week 24)
  • Changes in Anxiety(Week 24)
  • Changes in Pain and Disability(Week 24)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ryan Bradley

Director of Research

National University of Natural Medicine

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
Calcium Intake Fracture Outcome StudyOsteoporosis
ACTRN12615000750583niversity of Western Australia1,474
Completed
Phase 1
Aquamin and Prevention of Colon CancerColonic Cancer
NCT02647671James Varani36
Recruiting
Not Applicable
Zypan Functional DyspepsiaDyspepsia
NCT06320379National University of Natural Medicine64
Completed
Phase 3
Calcium Supplementation in Postmenopausal WomenOsteoporosis
NCT00172172Shire374
Unknown
Not Applicable
Calcium Over Postprandial Effects of Fatty Meal on Metabolism, Blood Pressure, Oxidative Stress, Endothelial Function.Obesity
NCT02137434Rio de Janeiro State University15